The European Medicines Agency has launched a new version of the European database on pharmaceutical manufacturing and import authorisations (EudraGMP) that allows public access to information from all competent authorities within the European Economic Area1.
The European Medicines Agency has launched a new version of the European database on pharmaceutical manufacturing and import authorisations (EudraGMP) that allows public access to information from all competent authorities within the European Economic Area1.
While the database has been in place since May 2007, it was made accessible to the public only in 2009...
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
A new pilot aims to take Brazil closer to ‘digital transformation.’
